After two neutropenia treatment-related deaths occurred during study accrual, the data monitoring committee recommended granulocyte colony-stimulating factor after docetaxel treatments, which helped reduce the number of grade 3–4 neutropenia adverse events. Here, CSF3 is linked to Decreased total neutrophil count.